InvestorsHub on MSN
Aquestive shares slide after FDA flags issues in Anaphylm filing
Aquestive Therapeutics (NASDAQ:AQST) saw its shares plunge about 40% on Friday after the company said the U.S. Food and Drug ...
Shares of Replimune Group Inc. (NASDAQ:REPL) plunged 36% in premarket trading after a report revealed new details about the internal dynamics behind the FDA’s rejection of its skin cancer treatment, ...
Drugmakers told the FDA that inflexible post-approval change requirements are among the top regulatory barriers to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback